Trials / Completed
CompletedNCT02539537
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
A Randomized Phase III Trial Comparing Chemotherapy With Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 171 (actual)
- Sponsor
- UNICANCER · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
French national multicentric phase III trial evaluating chemotherapy with Folfirinox or gemcitabine in locally advanced pancreatic carcinoma.
Detailed description
Comparative interventional prospective phase 3, randomized, open-label, multicentric trial comparing chemotherapy with Folfirinox to Gemcitabine in locally advanced pancreatic carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcitabine | |
| DRUG | Folinic Acid | |
| DRUG | 5-Fluoro-uracil | |
| DRUG | Oxaliplatin | |
| DRUG | Irinotecan | |
| DRUG | L-folinic |
Timeline
- Start date
- 2015-10-23
- Primary completion
- 2022-02-01
- Completion
- 2023-09-25
- First posted
- 2015-09-03
- Last updated
- 2024-01-09
Locations
45 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02539537. Inclusion in this directory is not an endorsement.